Effects of Cabozantinib, a small molecule tyrosine kinase inhibitor, on the immune permissiveness of the tumor microenvironment and immune-mediated killing of tumor cells

Documenti analoghi

• Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine
  di: Kwilas, Anna R, et al.
  Pubblicazione: (2014)
• Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway
  di: Ardiani, Andressa, et al.
  Pubblicazione: (2014)
• Androgen deprivation therapy increases the sensitivity of human prostate carcinoma cells to T cell-mediated lysis through an androgen receptor dependent mechanism
  di: Gameiro, Sofia, et al.
  Pubblicazione: (2014)
• Immune consequences of tyrosine kinase inhibitors that synergize with cancer immunotherapy
  di: Kwilas, Anna R., et al.
  Pubblicazione: (2015)
• Modulation of cabozantinib efficacy by the prostate tumor microenvironment
  di: Tripathi, Manisha, et al.
  Pubblicazione: (2017)